| Literature DB >> 15159015 |
Antonella Miglietta1, Maria Luisa Panno, Francesca Bozzo, Ludovica Gabriel, Claudia Bocca.
Abstract
Insulin regulates metabolism through homologous receptor tyrosine kinases, and plays a role in proliferation of breast cancer cells. Our research studied whether insulin, administered separately or in combination with paclitaxel, interferes with paclitaxel-mediated biological activity in human breast cancer cells. Not only did insulin influence paclitaxel-mediated cell microtubule reorganization, but it also influenced MCF-7 cell sensitivity to paclitaxel. Furthermore, combined administrations of insulin and paclitaxel affected MAPK pathway, Raf-1 activation and p53 expression levels. Our findings indicate that insulin seems to modulate MCF-7 cell response to paclitaxel; consequently, elevated levels of insulin could influence tumor cell resistance. Copyright 2004 Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15159015 DOI: 10.1016/j.canlet.2003.12.023
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679